You are here

XIMEREX, INC.

Company Information
Address
2614 N. 161 AVE.
OMAHA, NE -
United States



Information

UEI: N/A

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Ex Vivo Tolerance for Xenotransplantation of Diabetes P2

    Amount: $2,000,000.00

    DESCRIPTION (provided by applicant): Type I diabetes is a widespread disease in which insulin producing pancreatic islets are lost, leading to unstable glucose levels. If the islets can be replaced, ...

    SBIRPhase II2012Department of Health and Human Services National Institutes of Health
  2. PERV Free Swine for Xenotransplantation

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): There is a huge disparity between the number of patients who need a transplant and the available organ donors. Pigs could readily resolve the unmet need. The physi ...

    SBIRPhase I2008Department of Health and Human Services National Institutes of Health
  3. Ex Vivo Induction of Tolerance for Autoimmune Diabetes

    Amount: $1,267,090.00

    DESCRIPTION (provided by applicant): Transplantation of human has proved to be most beneficial for patients with end stage organ failure or loss of critical cells. For example, the transplantation of ...

    SBIRPhase I2008Department of Health and Human Services National Institutes of Health
  4. Heart Xenotransplantation with Chimeric Donor Pigs

    Amount: $1,086,680.00

    DESCRIPTION (provided by applicant): The transplantation of heart grafts can dramatically provide a long and productive life to recipients with heart failure. Typical transplant survivals are more th ...

    SBIRPhase I2005Department of Health and Human Services National Institutes of Health
  5. Islet Transplantation with Chimeric Donor Pigs

    Amount: $3,000,000.00

    More than 1 million Americans have type I (insulin dependent) diabetes. Transplantation of human islets, with the appropriate immune suppression, can provide a long-term insulin free cure. However, th ...

    SBIRPhase II2004Department of Health and Human Services National Institutes of Health
  6. Human/Pig Model of Hepatitis C Virus for New Vaccines

    Amount: $640,964.00

    DESCRIPTION (provided by applicant): Hepatitis C virus (HCV) has emerged as a major public health problem. World wide, as many as 200 million people are infected. In the United States, an estimated 3. ...

    SBIRPhase I2004Department of Health and Human Services National Institutes of Health
  7. N/A

    Amount: $100,000.00

    N/A

    SBIRPhase I2000Department of Health and Human Services National Institutes of Health
  8. Surrogate Tolerogenesis for Xenotransplantation

    Amount: $726,828.00

    The primary problem in organ transplantation today is the shortage of human donors. A proposed soluuse of pigs, but the risk of rejection is currently too great. The ultimate goal for transplant recis ...

    SBIRPhase II1997Department of Health and Human Services
  9. Surrogate Tolerogenesis for Xenotransplantation

    Amount: $99,992.00

    N/A

    SBIRPhase I1995Department of Health and Human Services
US Flag An Official Website of the United States Government